Jaw osteonecrosis in patients treated with bisphosphonates: MDCT evaluation;Osteonecrosi mascellare in pazienti trattati con bifosfonati: Valutazione con TC-MD

Radiologia Medica

Volumn 112, Issue 4, 2007, Pages 603-611

  Milillo, P ^a,e   Garribba, A P ^b   Favia, G ^c   Ettorre, G C ^d  

^a Direzione Sanitaria Azienda Ospedaliera Universitaria OORR Foggia   (Italy)

^b DI VENERE HOSPITAL   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e NONE   (Italy)

Author keywords

Bisphosphonates; Jaw; MDCT; Oral surgery; Osteonecrosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ZOLEDRONIC ACID;

ARTICLE; BONE METASTASIS; BONE NECROSIS; BONE PAIN; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FISTULA; HUMAN; JAW NECROSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE MYELOMA; ORAL SURGERY; OROSINUSAL FISTULA; OSTEOPOROSIS; PANCREAS CANCER; PARESTHESIA; PROSTATE CANCER; SOFT TISSUE INFECTION; TASTE DISORDER; TEMPOROMANDIBULAR JOINT; TOOTH EXTRACTION; TREATMENT DURATION;

ANTINEOPLASTIC AGENTS; DIPHOSPHONATES; HUMANS; JAW DISEASES; OSTEONECROSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447119473     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-007-0155-3     Document Type: Article

References (20)

1. Bagger YZ, Tanko LB, Alexandersen P et al (2003) Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal. Bone 33:301-307
2. Lenz JH, Steiner-Krammer B, Schmidt W et al (2005) Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates? J Craniomaxillofac Surg 33:395-403
3. Bjarnason NH (2004) Ten years of alendronate treatment for osteoporosis in postmenopausal women. N Engl J Med 351:190-192
4. Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Invest 97:2692-2696
5. Ficarra G, Beninati F, Rubino I et al (2005) Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32: 1123-1128. DOI: 10.1111/j.1600-051X.2005.00842
6. Sahni M, Guenther HL, Fleisch H et al (1993) Bisphosphonates act on rat bone resorption through the mediation of oteoblasts. J Clin Invest 91:2004
7. Zometa - zoledronic acid - injection and Aredia - pamidronate disodium - injection Oncologic Drugs Advieory Committee Meeting March 4, 2005
8. Marx RE, Sawatary Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567-1575
9. Schwartw HC (1982) Osteonecrosis of the Jaws: a complication of cancer chemotherapy. Head Neck Surg 4:251-253
10. Maduro JH, Pras E, Willemse PH, de Vries EG (2003) Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 29:471-488
11. Migliorati CA (2003) Bisphoshonates and oral cavity avascular bone necrosis. J Clin Oncol 21:4253-4254
12. Hellstein JW, Marek, CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63:682-689
13. Marx RE (2003) Pamidronate (Aredia) and zolendronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115-1117
14. Hillner BE, Ingle JN, Chlebowski RT et al (2003) American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21:4042-4057
15. Rosenberg TJ, Ruggiero S (2003) Osteonecrosis of the jaws associated with the use of bisphosphonates. J Oral Maxillofac Surg 61(suppl 1):60
16. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527-534
17. Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonatesassociated osteonecrosis of mandibular and maxillary bone. An emerging oral complication of supportive cancer therapy. Cancer 104:83-93
18. Vannucchi AM, Ficarra G, Antonioli E, Bosi A (2005) Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 128:738
19. Lugassy G, Shaham R, Nemets A et al (2004) Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117:440-441
20. Hansen T, Kunkel M, Weber A, Kirkpatrick JC (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155-160